Loading...
•
Dec 31, 2024
3D Systems Q4 2024 Earnings Report
3D Systems reported a revenue decline and a net loss in Q4 2024, impacted by a change in accounting estimates in its Regenerative Medicine program.
Key Takeaways
3D Systems' Q4 2024 revenue fell 3% year-over-year to $111 million, largely due to an $8.7 million adjustment tied to its Regenerative Medicine program. The company posted a net loss of $33.7 million and continued efforts to cut costs, while non-GAAP EPS came in at -$0.19.
Q4 revenue declined 3% year-over-year to $111 million.
Reported EPS was -$0.25; non-GAAP EPS was -$0.19.
Gross profit margin decreased to 31.0% from 38.3% last year.
Healthcare revenue dropped 21% while Industrial revenue rose 11%.
Revenue by Segment
Forward Guidance
3D Systems expects flat to modest revenue growth for FY2025, aiming for break-even or better adjusted EBITDA by Q4.
Positive Outlook
- New products gaining traction in Healthcare and Industrial markets.
- Full-year 2025 revenue expected to reach $420M to $435M.
- Cost reduction plan expected to deliver $50M in annual savings.
- Geomagic platform divestiture to boost cash reserves.
- Improved utilization rates in installed printer base.
Challenges Ahead
- Accounting estimate change negatively impacted Q4 results.
- Healthcare segment revenue declined sharply year-over-year.
- Operating loss and adjusted EBITDA remained negative.
- Macroeconomic uncertainty impacting capital spending.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...